EUVIMEDEUVIMED entdecken
Multizentrische Studie

The Frontier V Study: Evaluating the Safety and Clinical Performance of a Large‐Bore Vascular Closure Device After Femoral Arterial Access

Christian Frerker iD, Arne Schwindt, Andrej Schmidt, Tobias Schmidt, Guillaume Bonnet, Daniela Branzan, Lionel Leroux, Nicolas M Van Mieghem iD, Vasileios Panoulas, Christopher Martin, Fernando Gatto, Frontier V Investigators

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.31574 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Christian Frerker und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Hospital of Schleswig-Holstein, Lübeck, Germany. Hauptthemen laut MEDLINE: Catheterization, Peripheral, Endovascular Procedures, Femoral Artery, Hemorrhage. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Gefördert von: This study was supported by Vivasure Medical Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Vascular complications following large‐bore procedures may have a significant impact on patient morbidity and mortality, highlighting the critical need for an effective, safe, and reproducible closure device. We present our prospective multi‐center experience with a novel patch‐based closure device.

Aim

To evaluate the safety and clinical performance of the PerQseal+ closure system in achieving hemostasis after femoral arterial large‐bore access with 14–22 F sheaths.

Methods

The Frontier V study (NCT04799769) is a multicenter study that included patients undergoing an endovascular procedure requiring femoral access created by 14−22 F sheaths. The primary safety outcome was major access site complications related to the PerQseal+. The primary efficacy outcome was the technical success rate of device deployment. Secondary outcomes included minor access site complications related to the device, time to hemostasia, time to deployment, and time to total closure.

Results

A total of 88 subjects were included at seven investigational centers in Europe. One device‐related major access site complication (i.e., retroperitoneal hematoma) occurred (1.1%). The acute success rate of device deployment was 95%. There were five minor vascular access site complications directly related to the device (5.7%). The median time of device deployment was 5 min, the median time to achieve hemostasia was 1 min, and the median total closure time was 6 min.

Conclusion

The PerQseal+ closure device was safe and effective for large‐bore arterial femoral closure. These results highlight its potential as a reliable alternative for large‐bore closure in endovascular procedures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Catheterization, PeripheralEndovascular ProceduresFemoral ArteryHemorrhageHemostatic TechniquesVascular Closure DevicesAgedAged, 80 and overFemaleHumansMaleMiddle AgedEquipment DesignEuropeProspective StudiesPuncturesRisk FactorsTime FactorsTreatment Outcome

Stichwörter der Autor:innen

EVARTAVRfemoral arterial accesslarge bore arterial accessvascular closure devicevascular complications

Autor:innen und Institutionen

  • Department of Cardiology, University Hospital of Schleswig-Holstein, Lübeck, Germany.
  • German Center for Cardiovascular Research (DZHK), Partner Site Hamburg-Kiel-Lübeck, Lübeck, Germany.
  • Department of Vascular Surgery, St. Franziskus Hospital Münster, Münster, Germany.
  • Clinic and Polyclinic for Angiology, Medical Faculty of the University Leipzig, Leipzig, Germany.
  • Department of Cardiology, Asklepios Westklinikum, Hamburg, Germany.
  • RHU Envisage, ANR-23-RHUS-0007, Münster, France.

ORCID-Profile: Christian Frerker, Nicolas M Van Mieghem

Förderung

  • This study was supported by Vivasure Medical Ltd.

Zitieren

APA

Frerker, C., Schwindt, A., Schmidt, A., Schmidt, T., Bonnet, G., Branzan, D., Leroux, L., Van Mieghem, N. M., Panoulas, V., Martin, C., Gatto, F., & Frontier V Investigators (2025). The Frontier V Study: Evaluating the Safety and Clinical Performance of a Large‐Bore Vascular Closure Device After Femoral Arterial Access. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31574

Vancouver

Frerker C, Schwindt A, Schmidt A, Schmidt T, Bonnet G, Branzan D, et al. The Frontier V Study: Evaluating the Safety and Clinical Performance of a Large‐Bore Vascular Closure Device After Femoral Arterial Access. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31574

BibTeX
@article{Frerker2025,
  author = {Frerker, Christian and Schwindt, Arne and Schmidt, Andrej and Schmidt, Tobias and Bonnet, Guillaume and Branzan, Daniela and Leroux, Lionel and Van Mieghem, Nicolas M and Panoulas, Vasileios and Martin, Christopher and Gatto, Fernando and Frontier V Investigators, Frontier V Investigators},
  title = {The Frontier V Study: Evaluating the Safety and Clinical Performance of a Large‐Bore Vascular Closure Device After Femoral Arterial Access},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.31574}
}
Kostenlos starten →